Events2Join

Enliven Therapeutics Inc Company Profile


Enliven Therapeutics | Small Molecule Kinase Inhibitors

We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and ...

Enliven Therapeutics: Investor Relations

Corporate Profile. Enliven Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors ...

Enliven Therapeutics Company Profile 2024 - PitchBook

Enliven Therapeutics ; HQ Location. Boulder, CO ; Employees. 52 as of 2024 ; Primary Industry. Biotechnology ; Company Name Tempest Therapeutics ; Financing Status ...

Enliven Therapeutics Inc - Company Profile and News

Company profile page for Enliven Therapeutics Inc including stock price, company news, executives, board members, and contact information.

Enliven Therapeutics, Inc. (ELVN) Company Profile & Facts

See the company profile for Enliven Therapeutics, Inc. (ELVN) including business summary, industry/sector information, number of employees, business summary ...

Enliven Therapeutics Inc Company Profile - Overview - GlobalData

Enliven Therapeutics Inc company profile analysis with the premuim data - Globaldata.

Enliven Therapeutics - Crunchbase Company Profile & Funding

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Enliven Therapeutics, Inc. (ELVN) Company Profile & Overview

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients ...

Enliven Therapeutics, Inc.: Shareholders Board Members Managers ...

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help ...

Enliven Therapeutics - LinkedIn

Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not ...

Enliven Therapeutics, Inc. Company Profile | Boulder, CO

Just $139.99 * ; Where is Enliven Therapeutics, Inc. located? Enliven Therapeutics, Inc. is located at 6200 Lookout Rd Boulder, CO, 80301-3319 United States.

Enliven Therapeutics Inc. Company & People | ELVN - Barron's

Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small ...

Enliven Therapeutics, Inc. (ELVN) company profile and facts

See the company profile for Enliven Therapeutics, Inc. (ELVN), including business summary, industry/sector information, number of employees, ...

Enliven Therapeutics - Company Profile - Tracxn

Enliven Therapeutics - Developer of drugs for solid tumours and blood cancers. Public Company. Raised a total funding of $140M over 5 rounds ...

Board of Directors | Scientific Advisors - Enliven Therapeutics

We are a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help people with cancer.

Enliven Therapeutics Inc (ELVN) Company Profile & Statistics

Enliven Therapeutics Inc (ELVN) company information, summary key statistics, and financial ratios from FXEmpire.

Enliven Therapeutics Inc - Company Profile - GlobalData

Enliven Therapeutics Inc (Enliven Therapeutics), formerly a Imara Inc, is a clinical-stage precision oncology company that discovers and develops small molecule ...

Enliven Therapeutics - LeadIQ

Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live.

0001193125-20-038557 | S-1 - Enliven Therapeutics

Document Details. Form. S-1. Filing Date. February 14, 2020. Document ... Registration Statements. Company. Enliven Therapeutics. Issuer. ENLIVEN THERAPEUTICS, ...

Enliven Therapeutics Announces $90 Million Private - GlobeNewswire

Enliven Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help ...